Stock Under $10 with 50-100% upside potential - 14 Days FREE!

7 Stocks Under $10 With Relative Strength

Stock quotes in this article: JMBA, RIMM, CADX, DSCO, CECO, TTHI, ATRS 

Transition Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Transition Therapeutics (TTHI) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets. This stock is trading up 6% at $2.25 in recent trading.

Today's Range: $2.12-$2.25

52-Week Range: $1.15-$3.00

Volume: 5,916

Three-Month Average Volume: 19,118

>>22 Biopharma Stocks With Breakout Potential

From a technical perspective, TTHI is jumping to the upside here with light volume. This move has pushed the stock into near-term breakout territory, since TTHI has taken out some resistance at $2.16. Traders should now look to play the next major breakout trade for TTHI. That trade will trigger once TTHI takes out some near-term overhead resistance at $2.35 with high-volume.

Traders should look for long-biased trades once TTHI sustains a move or close over $2.35 with volume that's near or above 19,118 shares. If that breakout triggers soon, then TTHI has an excellent chance of tagging its next major overhead resistance levels at $2.79 to $3.23 in the near future.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,344.57 9.29 0.06%
NASDAQ 3,492.35 -4.08 -0.12%
S&P 500 1,666.55 0.26 0.02%
US 10 Yr 1.986% +0.021

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs